| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 65,538 | 66,067 | 64,111 | 74,278 | | Cost of Revenue | 38,389 | 39,077 | 40,066 | 41,299 | | | Gross Profit | 27,149 | 26,990 | 24,045 | 32,979 | | | Operating Expenses | | Research Development | 3,714 | 4,576 | 2,970 | 4,725 | | Selling General and Administrative | 14,939 | 15,169 | 13,554 | 14,199 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 8,496 | 7,245 | 7,521 | 14,055 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (73) | 1,215 | 1,460 | (2,877) | | Earnings Before Interest And Taxes | 8,423 | 8,460 | 8,981 | 11,178 | | Interest Expense | 24 | 28 | 68 | 57 | | Income Before Tax | 8,399 | 8,432 | 8,913 | 11,121 | | Income Tax Expense | 2,100 | 2,167 | 2,177 | 2,782 | | Minority Interest | 7 |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,299 | 6,265 | 6,736 | 8,339 | | | Non-recurring Events | | Discontinued Operations |
-
| (148) | (1,926) | 20 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,306 | 6,117 | 4,810 | 8,359 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,306 | $6,117 | $4,810 | $8,359 |
|
0.03% Nasdaq 0.00%
Income Statement
